Patents for C12P 21 - Preparation of peptides or proteins (112,499)
03/1996
03/20/1996EP0701606A1 Method of enhancing thrombolysis
03/20/1996EP0701573A1 Genetically engineered immunoglobulins
03/20/1996EP0701570A1 Thermoresistant alpha-1-antitrypsin mutein
03/20/1996EP0701569A1 Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
03/20/1996EP0701401A1 Adenoviral vectors including dna encoding lung surfactant protein
03/20/1996EP0355140B1 Human monoclonal anti-hiv-i-antibodies
03/20/1996EP0280710B1 Dna encoding the t cell surface protein t4 and use of fragments of t4 in the treatment of aids
03/20/1996CN1119027A Method of controlling insects in plants
03/20/1996CN1119026A Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion
03/20/1996CN1118983A Tomato spotted wilt virus
03/19/1996US5500362 Chimeric antibody with specificity to human B cell surface antigen
03/19/1996US5500360 RNA transformation vector
03/19/1996US5500348 Basophil-binding monoclonal antibody, method for separation of basophils, method for chemical mediator release from basophils, and method for testing release of basophil-derived chemical mediators
03/19/1996US5500347 Diagnosis of cancerous tumors and determination of their origin
03/19/1996US5500215 Immunology
03/19/1996CA2002515C Expression enhancer and use thereof to increase the yield in the expression of recombinant genes
03/19/1996CA1338171C Antibiotic, mersacidin, a process for the preparation thereof and the use thereof as a pharmaceutical
03/17/1996CA2158395A1 Coccidiosis poultry vaccine
03/14/1996WO1996007754A1 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
03/14/1996WO1996007753A1 Amino acid conjugate
03/14/1996WO1996007745A2 Mycobacteria functional screening and/or expression vectors
03/14/1996WO1996007744A1 A method of improved production of insulin-like growth factor
03/14/1996WO1996007740A1 Monoclonal recombinant anti-rhesus d (d7c2) antibody
03/14/1996WO1996007739A2 Interleukin-1 type 3 receptors
03/14/1996WO1996007738A2 Modified human c3 proteins
03/14/1996WO1996007735A1 Novel deoxyribonuclease
03/14/1996WO1996007734A2 Recombinant adenovirus comprising a chimeric penton base protein
03/14/1996WO1996007728A1 Production and secretion of recombinant fibrinogen by yeast
03/14/1996WO1996007313A1 A plant promoter useful for directing the expression of foreign proteins to the plant epidermis
03/14/1996WO1996006168A3 Retinoblastoma protein-interacting zinc finger proteins
03/14/1996WO1996005306A3 In vivo mutations and polymorphisms in the 17q-linked breast and ovarian cancer susceptibility gene
03/14/1996WO1996004378A3 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2
03/14/1996WO1996001425A3 Assay for inhibitors of dp-1 and other dp proteins
03/14/1996WO1995035376A3 Polypeptides with interleukin 8 receptor 1 (il8r1) binding domains
03/14/1996WO1995035111A3 USE OF βGalNac(1-4)βGal CONJUGATES TO TREAT CANDIDA INFECTION
03/14/1996WO1995034651A3 Corticotropin-releasing factor2 receptors
03/14/1996CA2199609A1 Interleukin-1 type 3 receptors
03/14/1996CA2198935A1 Monoclonal recombinant anti-rhesus d (d7c2) antibody
03/14/1996CA2198928A1 Production and secretion of recombinant fibrinogen by yeast
03/14/1996CA2198870A1 A plant promoter useful for directing the expression of foreign proteins to the plant epidermis
03/14/1996CA2198861A1 Recombinant adenovirus comprising a chimeric penton base protein
03/14/1996CA2197888A1 Modified human c3 proteins
03/13/1996EP0700998A1 Recombinant mersacidin and a method for production
03/13/1996EP0700997A1 Production in bacteria and yeast of hemoglobin and analogues thereof
03/13/1996EP0700994A1 Anti-igf-i monoclonal antibody
03/13/1996EP0700993A1 Anti-thymosin alpha 1 monoclonal antibody-producing hybridoma
03/13/1996EP0700446A1 Antibodies specific for dcc gene product
03/13/1996EP0700445A1 Stress proteins and uses therefor
03/13/1996EP0700444A1 Immunotoxins comprising gelonin and an antibody
03/13/1996EP0700443A1 Cho cell sialidase disrupted by recombinant dna technology
03/13/1996EP0700441A1 Multiple sclerosis virus
03/13/1996EP0700440A1 Regulator of contact-mediated hemolysin
03/13/1996EP0700439A1 Lymphocyte chemoattractant factor and uses thereof
03/13/1996EP0700438A1 Opioid receptors: compositions and methods
03/13/1996EP0700433A1 A method for hydrolysing proteins
03/13/1996EP0700430A1 Methods for selectively stimulating proliferation of t cells
03/13/1996EP0700402A1 Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies
03/13/1996EP0700401A1 Human calcium sensor
03/13/1996EP0700305A1 Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them
03/13/1996EP0567562B1 Methods for detecting glucagon antagonists
03/13/1996EP0550691B1 Antibody inductor peptides inhibiting retroviruses of the hiv type and antibodies specific for said peptides
03/13/1996EP0528932B1 Acute pancreatitis associated protein and means for the diagnosis of acute pancreatitis
03/13/1996EP0502962B1 Hirudinmuteins and their polyalkylene glycol conjugates
03/13/1996EP0491007B1 Structural alterations of the egf receptor gene in human gliomas
03/13/1996EP0436545B1 Therapeutic methods using catalytic antibodies
03/13/1996EP0435911B1 Cell culture medium for enhanced cell growth, culture longevity and product expression
03/13/1996EP0428602B1 Polypeptides and dna encoding same
03/12/1996US5498697 Protein possessing metastasis-inhibitory activity
03/12/1996US5498538 Totally synthetic affinity reagents
03/12/1996US5498499 Peptides and antibodies that inhibit platelet adhesion
03/10/1996CA2145905A1 Anti-thymosin .alpha.1 monoclonal antibody-producing hybridoma
03/07/1996WO1996007103A1 Methods and test kits for specific and sensitive diagnosing of periodontal diseases
03/07/1996WO1996007096A1 AN IN VITRO SYSTEM FOR DETERMINING FORMATION OF Aβ AMYLOID
03/07/1996WO1996006943A1 Cell cycle regulated repressor and dna element
03/07/1996WO1996006940A1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle
03/07/1996WO1996006939A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
03/07/1996WO1996006937A1 Improvements in production of proteins in host cells
03/07/1996WO1996006933A1 Gene therapy for transplantation and inflammatory or thrombotic conditions
03/07/1996WO1996006932A1 Plant transcription regulators from circovirus
03/07/1996WO1996006862A1 Gabaa receptor epsilon subunit
03/07/1996WO1996006861A1 Trefoil peptide dimer
03/07/1996WO1996006859A1 Trophic factors for central nervous system regeneration
03/07/1996WO1996006627A1 Mutant enterotoxin effective as a non-toxic oral adjuvant
03/07/1996WO1996006619A1 Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof
03/07/1996WO1996004385A3 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
03/07/1996WO1995032291A3 Hepatitis g virus and molecular cloning thereof
03/07/1996DE19532001A1 New antibacterial peptide, moricin, from silkworms
03/07/1996CA2198587A1 Trophic factors for central nervous system regeneration
03/07/1996CA2198474A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
03/07/1996CA2198473A1 Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound
03/07/1996CA2198472A1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle
03/07/1996CA2198345A1 Improvements in production of proteins in host cells
03/07/1996CA2198080A1 Cell cycle regulated repressor and dna element
03/07/1996CA2197452A1 Methods and test kits for specific and sensitive diagnosing of periodontal diseases
03/07/1996CA2197427A1 Gene therapy for transplantation and inflammatory or thrombotic conditions
03/06/1996EP0699766A1 Therapeutic antibody based fusion proteins with platelet factor-4
03/06/1996EP0699764A1 A method of using eukaryotic expression vectors comprising the BK virus enhancer
03/06/1996EP0699758A1 Prototype felv isolates for use in disease models and vaccines
03/06/1996EP0699756A1 Novel mutant BR96 antibodies and functional equivalents reactive with human carcinomas
03/06/1996EP0699755A2 Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains, compositions containing them